Login / Signup

Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment.

Heinz GisslingerChristoph KladePencho GeorgievDorota KrochmalczykLiana Gercheva-KyuchukovaMiklos EgyedPetr DulicekArpad IllesHalyna PylypenkoLylia SivchevaJiří MayerVera YablokovaKurt KrejcyVictoria EmpsonHans Carl HasselbalchRobert KralovicsJean-Jacques Kiladjiannull null
Published in: Leukemia (2023)
Keyphrases
  • free survival
  • replacement therapy
  • newly diagnosed
  • combination therapy